NCT05142176

Brief Summary

Many analgesic modalities have been investigated in pediatrics. The analgesic efficacy of bilateral ultrasound-guided erector spinae plane block in pediatric patients undergoing open midline sternotomy will be examined. Methods: 60 patients aged 3- 12 years will be randomly assigned into two groups: Control group will receive general anesthesia with bilateral sham erector spinae plane block at the level of T6 transverse process using 0.3 ml/kg normal saline on each side. Erector spinae plane block group will receive bilateral ultrasound-guided erector spinae plane block at the level of T6 transverse process using 0.3 ml/kg bupivacaine 0.25% (on each side) with a maximum dose of 2 mg/kg. The postoperative pain was assessed using Modified Objective Pain Scores (MOPS) which will be evaluated at 0, 1, 2, 4, 6, 8, 10, and 12 hours after extubation, total consumption of intraoperative fentanyl (1µg/kg IV in case of inadequate analgesia), time to first rescue analgesic administration and postoperative paracetamol consumption will be recorded over the first 24 hours postoperatively.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
75

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2022

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 6, 2021

Completed
26 days until next milestone

First Posted

Study publicly available on registry

December 2, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

February 5, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2022

Completed
Last Updated

February 1, 2022

Status Verified

December 1, 2021

Enrollment Period

2 months

First QC Date

November 6, 2021

Last Update Submit

January 31, 2022

Conditions

Outcome Measures

Primary Outcomes (7)

  • Modified Objective Pain Score (MOPS)0

    A rescue analgesic fentanyl, 0.5 to 1 mg/kg, will be administered when the MOPS score was≥ 4 at rest

    at immediately post extubation.

  • Modified Objective Pain Score (MOPS)1

    A rescue analgesic fentanyl, 0.5 to 1 mg/kg, will be administered when the MOPS score was≥ 4 at rest

    at1 hour post extubation.

  • Modified Objective Pain Score (MOPS)2

    A rescue analgesic fentanyl, 0.5 to 1 mg/kg, will be administered when the MOPS score was≥ 4 at rest

    at 2 hour post extubation.

  • Modified Objective Pain Score (MOPS)3

    A rescue analgesic fentanyl, 0.5 to 1 mg/kg, will be administered when the MOPS score was≥ 4 at rest

    at 4 hour post extubation.

  • Modified Objective Pain Score (MOPS)4

    A rescue analgesic fentanyl, 0.5 to 1 mg/kg, will be administered when the MOPS score was≥ 4 at rest

    at 6 hour post extubation.

  • Modified Objective Pain Score (MOPS)5

    A rescue analgesic fentanyl, 0.5 to 1 mg/kg, will be administered when the MOPS score was≥ 4 at rest

    at 8 hour post extubation.

  • Modified Objective Pain Score (MOPS)6

    A rescue analgesic fentanyl, 0.5 to 1 mg/kg, will be administered when the MOPS score was≥ 4 at rest

    at 12 hour post extubation.

Study Arms (2)

control group

PLACEBO COMPARATOR

will receive general anesthesia with bilateral sham erector spinae plane block at the level of T6 transverse process using 0.3 ml/kg normal saline on each side.

Other: Erector spinae catheters insertionDrug: Postoperative pain management

Erector spinae plane block group

ACTIVE COMPARATOR

will receive bilateral ultrasound-guided erector spinae plane block at the level of T6 transverse process using 0.3 ml/kg bupivacaine 0.25% (on each side) with a maximum dose of 2 mg/kg.

Other: Erector spinae catheters insertionDrug: Postoperative pain management

Interventions

Ultrasound-Guided ESPB The ESPB will be performed with the child in a right lateral decubitus position under aseptic precautions by a high frequency (6-13 MHz) linear ultrasound transducer

Erector spinae plane block groupcontrol group

IV acetaminophen 15 mg/kg every 8 hours as a component of multimodal analgesia.

Erector spinae plane block groupcontrol group

Eligibility Criteria

Age3 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • children undergoing cardiac surgical procedures through midline sternotomy

You may not qualify if:

  • The patients with preoperative ejection fraction \<35%
  • allergic to the amide type of local anesthetics (LA)
  • preoperative inotropic support

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Masking Details
Patients unaware and care giver were unaware about what is injected inthe catheters
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Bilateral erector spinae block
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

November 6, 2021

First Posted

December 2, 2021

Study Start

February 5, 2022

Primary Completion

March 30, 2022

Study Completion

March 30, 2022

Last Updated

February 1, 2022

Record last verified: 2021-12